Governance Guidance for Biopharma Board Members
Experience-based counsel for the people who sit in the boardroom and make the decisions. Not theory. Not checklists. The real work of governing clinical-stage companies.
Read the LatestWhat We Cover
Governance Fundamentals
The foundational knowledge that generic governance resources don't teach
Browse →Clinical-Stage Decision Making
The board's role in the decisions that define clinical-stage companies
Browse →Capital & Strategic Transactions
Financial governance, fundraising oversight, and exit preparation
Browse →Board Dynamics & Effectiveness
The human and organizational dimensions of board governance
Browse →Recent Articles
Managing the Tension Between Investor and Independent Directors
The tension between investor and independent directors is the most common source of board dysfunction in biopharma. It doesn't have to be.
Board Governance During Fundraising
Fundraising is when governance is most tested and most needed. Conflicts multiply, timelines compress, and the board's fiduciary duties become acutely complex.
The Board's Role in Trial Go/No-Go Decisions
Trial go/no-go decisions are among the most consequential a biopharma board will face. Getting the governance right means knowing where the board's role ends and management's begins.
Stay Informed
A weekly newsletter with governance insights, case studies, and analysis for biopharma board members.
No spam. Unsubscribe anytime.